Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 FDA committee votes to withdraw bevacizumab for breast cancer.

Authors: Ekaterini C Tampaki; Athanasios Tampakis; Constantinos E Alifieris; Dimitrios Krikelis; Anastasia Pazaiti; Michalis Kontos; Dimitrios T Trafalis
Journal: Clin Drug Investig Date: 2018-07 Impact factor: 2.859

5. SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.

Authors: Z A Nahleh; W E Barlow; D F Hayes; A F Schott; J R Gralow; W M Sikov; E A Perez; S Chennuru; H R Mirshahidi; S W Corso; D L Lew; L Pusztai; R B Livingston; G N Hortobagyi
Journal: Breast Cancer Res Treat Date: 2016-07-08 Impact factor: 4.872

6. Lack of correlation between the costs of anticancer drugs and clinical benefits in Japan.

Authors: Etsuko Satoh; Yasutsuna Sasaki; Ryotaro Ohkuma; Takehiro Takahashi; Yutaro Kubota; Hiroo Ishida; Kazuyuki Hamada; Yuji Kiuchi; Takuya Tsunoda
Journal: Cancer Sci Date: 2018-11-27 Impact factor: 6.716

7. The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.

Authors: Anita Yakkundi; Lynn McCallum; Anthony O'Kane; Hayder Dyer; Jenny Worthington; Hayley D McKeen; Lana McClements; Christopher Elliott; Helen O McCarthy; David G Hirst; Tracy Robson
Journal: PLoS One Date: 2013-02-15 Impact factor: 3.752

8. Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer.

Authors: Meenakshi Upreti; Amar Jyoti; Sara E Johnson; Elden P Swindell; Dana Napier; Pallavi Sethi; Ryan Chan; Jonathan M Feddock; Heidi L Weiss; Thomas V O'Halloran; B Mark Evers
Journal: Oncotarget Date: 2016-07-05

9. Growth of MCF-7 breast cancer cells and efficacy of anti-angiogenic agents in a hydroxyethyl chitosan/glycidyl methacrylate hydrogel.

Authors: Hejing Wang; Junmin Qian; Yaping Zhang; Weijun Xu; Juxiang Xiao; Aili Suo
Journal: Cancer Cell Int Date: 2017-05-16 Impact factor: 5.722

Review 10. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

Authors: Suzanne A Eccles; Eric O Aboagye; Simak Ali; Annie S Anderson; Jo Armes; Fedor Berditchevski; Jeremy P Blaydes; Keith Brennan; Nicola J Brown; Helen E Bryant; Nigel J Bundred; Joy M Burchell; Anna M Campbell; Jason S Carroll; Robert B Clarke; Charlotte E Coles; Gary J R Cook; Angela Cox; Nicola J Curtin; Lodewijk V Dekker; Isabel dos Santos Silva; Stephen W Duffy; Douglas F Easton; Diana M Eccles; Dylan R Edwards; Joanne Edwards; D Evans; Deborah F Fenlon; James M Flanagan; Claire Foster; William M Gallagher; Montserrat Garcia-Closas; Julia M W Gee; Andy J Gescher; Vicky Goh; Ashley M Groves; Amanda J Harvey; Michelle Harvie; Bryan T Hennessy; Stephen Hiscox; Ingunn Holen; Sacha J Howell; Anthony Howell; Gill Hubbard; Nick Hulbert-Williams; Myra S Hunter; Bharat Jasani; Louise J Jones; Timothy J Key; Cliona C Kirwan; Anthony Kong; Ian H Kunkler; Simon P Langdon; Martin O Leach; David J Mann; John F Marshall; Lesley Martin; Stewart G Martin; Jennifer E Macdougall; David W Miles; William R Miller; Joanna R Morris; Sue M Moss; Paul Mullan; Rachel Natrajan; James P B O'Connor; Rosemary O'Connor; Carlo Palmieri; Paul D P Pharoah; Emad A Rakha; Elizabeth Reed; Simon P Robinson; Erik Sahai; John M Saxton; Peter Schmid; Matthew J Smalley; Valerie Speirs; Robert Stein; John Stingl; Charles H Streuli; Andrew N J Tutt; Galina Velikova; Rosemary A Walker; Christine J Watson; Kaye J Williams; Leonie S Young; Alastair M Thompson
Journal: Breast Cancer Res Date: 2013-10-01 Impact factor: 6.466